DTIL (Precision BioSciences) Interest Expense: $-1.38 Mil (TTM As of Mar. 2026)

What is Precision BioSciences Interest Expense?

Precision BioSciences DTIL -4.37% 50 Interest Expense is $-1.38 Mil as of Mar. 2026. GuruFocus rates DTIL with a GF Score™ of 50/100 and a GF Value™ of $1.83 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Precision BioSciences's interest expense for the three months ended in Mar. 2026 was $ -0.31 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.38 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Precision BioSciences's Operating Income for the three months ended in Mar. 2026 was $ -9.08 Mil. Precision BioSciences's Interest Expense for the three months ended in Mar. 2026 was $ -0.31 Mil. Precision BioSciences did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Precision BioSciences (NAS:DTIL) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Precision BioSciences's Interest Expense for the three months ended in Mar. 2026 was $-0.31 Mil. Its Operating Income for the three months ended in Mar. 2026 was $-9.08 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $4.49 Mil.

Precision BioSciences's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Precision BioSciences did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Precision BioSciences Interest Expense Historical Data

* Premium members only.

The historical data trend for Precision BioSciences's Interest Expense can be seen below:

Precision BioSciences Interest Expense Chart

Precision BioSciences Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-0.13

-1.11

-2.23

-1.78

-1.42

Precision BioSciences Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-0.35	-0.36	-0.36	-0.35	-0.31

50GF Score

Precision BioSciences Inc DTIL

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Precision BioSciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.38 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-1.38 Mil mean?

Precision BioSciences (DTIL) has a Interest Expense of $-1.38 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Precision BioSciences and its competitors.

Is Precision BioSciences' Interest Expense too high?

Precision BioSciences' current Interest Expense is $-1.38 Mil. Overall, Precision BioSciences has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Precision BioSciences' Interest Expense compare to NBP and HUMA?

Precision BioSciences' Interest Expense of $-1.38 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Biotechnology company?

A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Precision BioSciences and its competitors. Precision BioSciences's current Interest Expense is $-1.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Precision BioSciences stock overvalued right now?

Based on GuruFocus' analysis, Precision BioSciences (DTIL) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.83, compared to a current price of $8.77 — trading 379% above its estimated fair value. The current Interest Expense is $-1.38 Mil. Precision BioSciences' overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Precision BioSciences (DTIL), the current Interest Expense is $-1.38 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Precision BioSciences (DTIL) Overvalued in 2026?

Based on GuruFocus' analysis, Precision BioSciences stock appears to be overvalued. The current stock price of $8.77 is trading 379% above its estimated GF Value™ of $1.83. GuruFocus considers Precision BioSciences to be Significantly Overvalued.

Key valuation signals for DTIL:

Interest Expense: $-1.38 Mil
GF Value™: $1.83 vs. price of $8.77 (379% above fair value)
GF Score™: 50/100 with 5 warning signs

No single metric tells the full story. See the DTIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Precision BioSciences Business Description

Industry Healthcare Biotechnology

Comparable Companies NBP HUMA ORMP EQ PLX OKUR ANTX ARCT MDWD UNCY VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges PBS0:Germany

Address 302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701

Website https://www.precisionbiosciences.com

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

50GF Score

Get the complete analysis for DTIL

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.77

Price

$1.83

GF Value

View DTIL Analysis

See Interest Expense data for all stocks →